Seattle startup rakes in $2M for hypertension remote monitoring system
The company, Sentinel Healthcare, plans to use the money to further develop its product and scale its customer base and patient population.
Michigan medtech company raises $77M for renal denervation solution to hypertension
While the development of renal denervation technologies stalled after a failed Medtronic study in 2014, recent positive research results have led to increasing interest - and investment - in the space.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Two top medical device companies announce promising renal denervation tech results
Two top medical device companies turned up the heat on the renal denervation competition. Both Boston Scientific (BSX) and St. Jude Medical (STJ) delivered promising results from studies on their two respective renal denervation technologies at the Transcatheter Cardiovascular Therapeutics conference in San Francisco. Such technology uses radiofrequency ablation on the nerves leading to the […]
Wow of the week: Blood-sucking robot could save one in 50 of us who will develop brain clot
Fear not–this blood-sucking robot could treat hard-to-reach brain hemorrhages. While most surgeons won’t go near a brain clot unless it’s easy to get to (read: on the surface) in fear of further damaging brain tissue, more than 40 percent of patients who have them die within a month. The active cannula, what Vanderbilt assistant professors […]
Could this study finally settle one mHealth, data-sharing debate?
The push for regular interaction between patients and doctors, for mHealth and for data transparency has only begun. But the results from Scripps Translational Science Institute‘s research may add even more fuel to the flame for mHealth and patient engagement. The organization will study whether integrating wireless, medtech and social networks can bring down the […]
Minnesota company raises $29.6 million for implantable hypertension technology
CVRx, a Minneapolis-based firm that has developed proprietary implantable technology for the treatment of high blood pressure and heart failure, has raised $29.6 million for advancing clinical trials of its Barostim Neo, as well as expanding commercial activities abroad. Johnson & Johnson Development Corp. and New Enterprise Associates, Inc. were the co-lead investors. According to […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.